资讯

Oruka Therapeutics Announces First Participants Dosed In Phase 1 Trial Of ORKA-002, Its ...
Pharmacokinetic and safety data from healthy volunteers anticipated around YE 2025 On track to initiate a Phase 2 study in 1H 2026 O ...